Vor Bio To Participate in Upcoming September Conferences

About this update from Vor Biopharma Inc.

BOSTON, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced that management will participate in the following investor conferences: Forum: Fireside Chat and 1x1 Meetings                         Date: Tuesday, September 8th                         Presentation Time: 8:00AM ET Forum: Fireside Chat and 1x1 Meetings                         Date: Wednesday, September 9th                         Presentation Time: 11:20AM ET Forum: 1x1 Meetings                         Date: Monday, September 14th Forum: Presentation and 1x1 Meetings                         Date: Tuesday, September 15th                         Presentation Time: 9:05AM ET Forum: Presentation and 1x1 Meetings                         Date: Wednesday, September 23rd                         Presentation Time: 11:30AM ET A live webcast of the presentation may be accessed on the Investors section of the Vor website at ir.vorbio.com. A replay of the webcast will be available on the Vor website for approximately 30 days following the presentation. About Vor Bio Vor Bio is a clinical-stage biotechnology company transforming the treatment of autoimmune diseases. The Company is focused on rapidly advancing telitacicept, a novel dual-target fusion protein, through Phase 3 clinical development and potential commercialization to address serious autoantibody-driven conditions worldwide. For more information visit www.vorbio.com . Vor Bio routinely posts information that may be important to investors in the "Investors" section of its website. The Company encourages investors to consult that section of its website regularly.

View stock analysis, news, and events for Vor Biopharma Inc.